- New partnership with cutting-edge life sciences company Oxford Nanopore will lead to better scientific research and could create tests and treatments for patients, saving lives
- Patients suspected of having severe acute respiratory infections will be diagnosed within 6 hours, supporting the establishment of a new diagnostic system
- Technology will allow potential outbreaks of bacterial or viral diseases to be monitored alongside antimicrobial resistance, shifting NHS from analogue to digital as part of 10 Year Health Plan
The UK will create the world’s first real-time surveillance system to monitor the threat of future pandemics, prevent disease and protect the public.
Plans have been announced to form a new partnership between the government, Genomics England, UK Biobank, NHS England and Oxford Nanopore – a UK-headquartered, world-leading life sciences company…